Build and manage your online surveys and databases with this secure web application that easily collects and exports data. REDCap (Research Electronic Data Capture) is a free, secure, HIPAA-compliant, web-based application used for electronic capture and management of research and clinical study data. Learn about other tools available through REDCap (MyCap, Mosio, and the Rochester Accessibility Survey) below.
Learn more about REDCap
MyCap
MyCap is a mobile app that participants or patients can download to complete research/clinical data collection from any mobile device. Available as an external module for REDCap, MyCap makes it simple and inexpensive (no-cost) for researchers to use a mobile app to capture patient reported outcomes on both iOS and Android devices. Learn more about MyCap.
Mosio
Mosio is a REDCap integration that enables efficient communication with research participants via text messaging as well as data collection. Researchers can use Mosio to text REDCap survey links, send nudge reminders to complete REDCap surveys, schedule appointment reminders, and have back-and-forth dialog with clinical trial participants. Learn more about Mosio.
Rochester Accessibility Survey
Designed with Deaf and DeafBlind people in mind, this external module for REDCap makes it easy to embed sign language videos into surveys, and allows survey participants to control text size and color and background color to optimize legibility. To use this module, log into REDCap, create or open your survey, click on “External Modules” in the “Applications” menu, click “View available modules” and search for “Rochester Accessibility Survey.”
National COVID Cohort Collaborative
The National COVID Cohort Collaborative (N3C) is an open science community that unites and harmonizes COVID patient data, enabling collaborative analytics across Clinical and Translational Science Awards Program hubs, including the University of Rochester.
Learn how you can engage N3C.
Cite the Clinical and Translational Science Award
The UR CTSI is supported in part by grants UL1 TR002001, KL2 TR001999, and TL1 TR002000 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). If you took advantage of our informatics tools or consultations, please cite the appropriate UR CTSI grants.
Visit our NIH Funding Acknowledgement webpage for grant citation language.
Spotlight
Twitter Users Soured on Flavored e-Cigs Following FDA Ban
Research led by UR CTSI scientists shows that Twitter users’ perceptions toward e-cigarettes changed following two policies from the FDA and New York state that banned flavored e-cigs. The researchers mined millions of tweets from Twitter users in the U.S. from before and after the policies were announced and enacted.
Read the full story.